Table 3 Top 5 provisional diagnoses/presenting condition and top 5 treatments according to age group and gender (Pink register data, 2 PHC, 6 months in 2015/16)
Total | Females | Males | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10-14 yrs | 15-19 yrs | 20-24 yrs | Total | 10-14 yrs | 15-19 yrs | 20-24 yrs | Total | 10-14 yrs | 15-19 yrs | 20-24 yrs | Total | |
(n=646) | (n=1224) | (n=1567) | (n=3437) | (n=327) | (n=956 ) | (n=1286) | (n=2569 ) | (n=319 ) | (n=268) | (n=281) | (n=868) | |
Provisional diagnoses/presenting condition | ||||||||||||
General non-specific complaints | 11.6% | 11.0% | 10.3% | 10.8% | 14.1% | 10.7% | 9.6% | 10.6% | 9.1% | 12.3% | 13.5% | 11.5% |
Skin problems | 7.7% | 3.4% | 2.0% | 3.6% | 8.0% | 2.6% | 2.2% | 3.1% | 7.5% | 6.0% | 1.4% | 5.1% |
Respiratory problems (excluding TB) | 13.5% | 7.3% | 4.9% | 7.4% | 16.5% | 6.2% | 3.9% | 6.3% | 10.3% | 11.2% | 9.6% | 10.4% |
TB and screening for TB | 2.0% | 1.6% | 2.5% | 2.1% | 2.5% | 0.8% | 1.6% | 1.4% | 1.6% | 4.5% | 6.8% | 4.2% |
HIVa | 28.2% | 10.2% | 15.3% | 15.9% | 22.0% | 9.0% | 15.1% | 13.7% | 34.5% | 14.6% | 16.4% | 22.5% |
GI problems | 4.3% | 4.4% | 3.2% | 3.8% | 4.3% | 3.7% | 2.4% | 3.1% | 4.4% | 7.1% | 6.8% | 6.0% |
Sexual Transmitted infection (excl. HIV) | 0.5% | 3.2% | 5.2% | 3.6% | 0.9% | 3.0% | 3.6% | 3.0% | 0.0% | 3.7% | 12.5% | 5.2% |
Sexual and Reproductive Healthb | 0.8% | 6.1% | 4.7% | 4.5% | 1.5% | 7.7% | 5.7% | 2.9% | 0.0% | 0.4% | 0.4% | 0.2% |
Family planning | 0.2% | 9.8% | 18.0% | 11.7% | 0.3% | 12.1% | 21.8% | 15.5% | 0.0% | 1.5% | 0.7% | 0.7% |
Antenatal care | 2.5% | 21.7% | 16.2% | 15.5% | 4.6% | 27.6% | 19.6% | 20.7% | 0.3% | 0.4% | 0.4% | 0.4% |
Trauma/injury | 7.6% | 4.8% | 2.1% | 4.1% | 5.8% | 2.5% | 0.9% | 2.1% | 9.4% | 13.1% | 7.8% | 10.0% |
Treatments | ||||||||||||
Antibiotics | 23.5% | 20.6% | 18.8% | 20.3% | 25.4% | 18.0% | 15.3% | 17.6% | 21.6% | 29.9% | 34.5% | 28.3% |
Anti-inflammatory | 0.3% | 1.4% | 1.7% | 1.3% | 0.6% | 1.3% | 1.1% | 1.1% | 0.0% | 1.9% | 4.3% | 2.0% |
Panadol/Aspirin | 10.5% | 8.7% | 7.2% | 8.4% | 12.5% | 8.4% | 6.8% | 8.1% | 8.5% | 9.7% | 9.3% | 9.1% |
Anti-retroviral treatment (ART) | 28.3% | 10.2% | 14.6% | 15.6% | 21.7% | 9.2% | 14.3% | 13.4% | 35.1% | 13.8% | 16.0% | 22.4% |
TB treatment | 0.5% | 0.5% | 1.9% | 1.1% | 0.9% | 0.1% | 1.2% | 0.7% | 0.0% | 1.9% | 5.3% | 2.3% |
Epileptic treatment | 2.8% | 0.0% | 1.4% | 1.9% | 2.8% | 1.4% | 0.8% | 1.3% | 2.8% | 4.5% | 4.3% | 3.8% |
Vitamins and supplements | 3.4% | 18.3% | 15.4% | 14.2% | 5.8% | 22.9% | 18.4% | 18.5% | 0.9% | 1.9% | 1.8% | 1.5% |
Vaccination | 5.0% | 3.1% | 1.0% | 2.5% | 4.9% | 2.3% | 0.5% | 1.7% | 5.0% | 6.0% | 3.2% | 4.7% |
Minor procedures/dressing | 4.5% | 2.7% | 2.7% | 3.0% | 2.5% | 2.5% | 3.0% | 2.7% | 6.6% | 3.4% | 1.4% | 3.9% |
Symptomatic treatmentc | 5.9% | 4.9% | 3.4% | 4.4% | 6.7% | 3.8% | 3.7% | 4.1% | 5.0% | 8.9% | 1.8% | 5.2% |
Family planning | 0.2% | 11.0% | 18.9% | 12.5% | 0.3% | 13.6% | 22.9% | 16.5% | 0.0% | 1.5% | 0.7% | 0.7% |